Company
Description
Shenzhen MLC is a high-tech innovation enterprise established in the Chinese mainland by HK MLC Investment, specializing in the research and development, manufacturing and sales of high-end medical devices. Founded in May 2025, the company is located in Shenzhen, a leading edge of China's technological innovation. Since its establishment, the company has been shouldering a clear mission: to reshape the paradigm of blood glucose management through disruptive technological innovation, providing an unprecedented intelligent and comprehensive health management experience for patients worldwide suffering from blood glucose problems and health-conscious individuals. We firmly believe that the highest value of technology lies in safeguarding life and health, and MLC is a steadfast practitioner of this belief.
Adhering to R&D-driven development and building technological barriers: MLC regards R&D as our lifeline. We have assembled a top-notch cross-disciplinary R&D team, gathering senior experts from various fields such as biomedical engineering, analytical chemistry, algorithm science, and clinical medicine from both domestic and international backgrounds. The parent company of the group invests a large amount of funds each year in core technology research and new product iteration, especially in the areas of sensor biocompatibility, enzyme electrode stability, anti-interference algorithms, and equipment miniaturization. We have established an independent intellectual property system and built a solid technological moat. Relying on the company's strong marketing network, the accumulated advantageous channel resources with over 80,000 partners in more than 174 countries, and our own R&D capabilities in blood glucose monitoring and management products, we are committed to becoming an important force in promoting the intelligent upgrade of the global health industry.
Taking advantage of regional advantages and achieving vertical integration: we deeply integrates into the innovative ecosystem of the GBA (Greater Bay Area), fully leveraging the world-class supply chain resources in microelectronics, sensors, new materials, battery energy, and precision manufacturing in Shenzhen and its surrounding areas. This enables us to efficiently transform from laboratory prototypes to large-scale production, strictly controlling every quality aspect from core sensors to the final products, ensuring the outstanding performance and reliability of the products.
Adhering to international quality and based on the global market: We strictly follow the medical device regulations and ISO13485 quality system standards of mainstream markets such as China NMPA, EU CE-MDR for product design and production. From raw material storage to finished product delivery, every process undergoes rigorous testing and verification to ensure that the products delivered to every user are safe, effective, and trustworthy.
Looking ahead to the future, Shenzhen MLC will never stop at a successful product. We will take CGM as the starting point and pivot, and continue to deepen our cultivation in the field of digital health monitoring. The company's long-term strategy is to gradually expand to intelligent management of other chronic diseases, such as continuous blood pressure monitoring, blood lipid monitoring, etc., and ultimately create a multidimensional personal health data center. From medical device manufacturers to health solution providers.
Shenzhen MLC will always adhere to the concept of "innovation leading, attentive protection", take CGM products as the starting point, and continuously deepen exploration in the field of digital health monitoring. Our goal is to not only become the pride of China's medical device industry by providing world-class quality medical device products and services, but also to step onto the world stage, serve the global market, and make practical contributions to the progress of human health.
